Read Full Article Here.
Academic Literature
Reforming the Payment System for Medical Oncology
Infusion of chemotherapy has long been a profit center for medical oncologists. Here are various approaches to cancer drug payment reform, and their strengths and weaknesses.
Originally published
on 07/17/2013
in
JAMA Viewpoint
Infusion of chemotherapy has long been a profit center for medical oncologists.
Under the current system, oncologists purchase cancer drugs at one price, then bill insurers at a higher price after they administer the drugs. However, the profits available to oncologists from this practice have been under serious pressure from the pharmaceutical industry and insurers.
Share